|
1
|
Yu YR and Rodriguez JR: Clinical
presentation of Crohn's, ulcerative colitis, and indeterminate
colitis: Symptoms, extraintestinal manifestations, and disease
phenotypes. Semin Pediatr Surg. 26:349–355. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cheng C, Hua J, Tan J, Qian W, Zhang L and
Hou X: Identification of differentially expressed genes, associated
functional terms pathways, and candidate diagnostic biomarkers in
inflammatory bowel diseases by bioinformatics analysis. Exp Ther
Med. 18:278–288. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ng SC, Tang W, Ching JY, Wong M, Chow CM,
Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, et al: Asia-Pacific
Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group:
Incidence and phenotype of inflammatory bowel disease based on
results from the Asia-pacific Crohn's and colitis epidemiology
study. Gastroenterology. 145:158–165.e2. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sartor RB and Wu GD: Roles for intestinal
bactetria, viruses, and fungi in pathogenesis of inflammatory bowel
diseases and therapeutic approaches. Gastroenterology.
152:327–339.e4. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kostic AD, Xavier RJ and Gevers D: The
microbiome in inflammatory bowel disease: Current status and the
future ahead. Gastroenterology. 146:1489–1499. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Michail S, Durbin M, Turner D, Griffiths
AM, Mack DR, Hyams J, Leleiko N, Kenche H, Stolfi A and Wine E:
Alterations in the gut microbiome of children with severe
ulcerative colitis. Inflamm Bowel Dis. 18:1799–1808.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen ZM, Peto R, Iona A, Guo Y, Chen YP,
Bian Z, Yang L, Zhang YY, Lu F, Chen JS, Collins R and Li LM: China
Kadoorie Biobank Collaborative Group. Emerging tobacco-related
cancer risks in China: A nationwide, prospective study of 0.5
million adults. Cancer. 121 (Suppl 17):3097–106. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lin Y, Yang X, Yue W, Xu X, Li B, Zou L
and He R: Chemerin aggravates DSS-induced colitis by suppressing M2
macrophage polarization. Cell Mol Immunol. 11:355–366.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Håkansson Å, Tormo-Badia N, Baridi A, Xu
J, Molin G, Hagslätt ML, Karlsson C, Jeppsson B, Cilio CM and Ahrné
S: Immunological alteration and changes of gut microbiota after
dextran sulfate sodium (DSS) administration in mice. Clin Exp Med.
15:107–120. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Paramsothy S, Kamm MA, Kaakoush NO, Walsh
AJ, van den Bogaerde J, Samuel D, Leong RW, Connor S, Ng W,
Paramsothy R, Xuan W, Lin E, Mitchell HM and Borody TJ: Multidonor
intensive faecal microbiota transplantation for active ulcerative
colitis: a randomised placebo-controlled trial. Lancet.
389:1218–28. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Weingarden AR and Vaughn BP: Intestinal
microbiota, fecal microbiota transplantation, and inflammatory
bowel disease. Gut Microbes. 8:238–252. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ishiguro Y, Ohkawara T, Sakuraba H,
Yamagata K, Hiraga H, Yamaguchi S, Fukuda S, Munakata A, Nakane A
and Nishihira J: Macrophage migration inhibitory factor has a
proinflammatory activity via the p38 pathway in
glucocorticoid-resistant ulcerative colitis. Clin Immunol.
120:335–341. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhou H, Wong YF, Wang J, Cai X and Liu L:
Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in
rats. Biochem Biophys Res Commun. 376:352–357. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yu XH, Wang YF, Dai FY, Zhao JH and Li P:
The protective effects of Berberine and Hesperidin on inflammatory
factor-stimulating cardiac fibroblasts. Eur Rev Med Pharmacol Sci.
23:5468–5476. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li W, Zhao X, Lv X, Han W and Wang H:
Silibinin retards colitis-associated carcinogenesis by repression
of Cdc25C in mouse model. Inflamm Bowel Dis. 25:1187–1195.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
DeVore NM and Scott EE: Nicotine and
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access
channel in human cytochrome P450 2A6 and 2A13 enzymes. J Biol Chem.
287:26576–26585. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhu L, Gu P and Shen H: Protective effects
of berberine hydrochloride on DSS-induced ulcerative colitis in
rats. Int Immunopharmacol. 68:242–251. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liang H, Liu P, Wang Y, Song S and Ji A:
Protective effects of alkaloid extract from Leonurus
heterophyllus on cerebral ischemia reperfusion injury by middle
cerebral ischemic injury (MCAO) in rats. Phytomedicine. 18:811–818.
2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang D, Jia W and Zhu YZ: Leonurine, a
potential agent of traditional Chinese medicine: Recent updates and
future perspectives. Nat Prod Commun. 11:1757–1761. 2016.PubMed/NCBI
|
|
20
|
Jin M, Li Q, Gu Y, Wan B, Huang J, Xu X,
Huang R and Zhang Y: Leonurine suppresses neuroinflammation through
promoting oligodendrocyte maturation. J Cell Mol Med. 23:1470–1485.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hu ZC, Gong LF, Li XB, Fu X, Xuan JW, Feng
ZH and Ni WF: Inhibition of PI3K/Akt/NF-κB signaling with leonurine
for ameliorating the progression of osteoarthritis: In vitro and in
vivo studies. J Cell Physiol. 234:6940–6950. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wu H, Dai A, Chen X, Yang X, Li X, Huang
C, Jiang K and Deng G: Leonurine ameliorates the inflammatory
responses in lipopolysaccharide-induced endometritis. Int
Immunopharmacol. 61:156–161. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang Z, Wu X, Cao S, Cromie M, Shen Y,
Feng Y, Yang H and Li L: Chlorogenic acid ameliorates experimental
colitis by promoting growth of Akkermansia in mice.
Nutrients. 9(E677)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
US National Institutes of Health (NIH):
Guide of the Care and Use of Laboratory Animals. NIH Publication,
pp852-853, 1996.
|
|
25
|
Han F, Zhang H, Xia X, Xiong H, Song D,
Zong X and Wang Y: Porcine β-defensin 2 attenuates inflammation and
mucosal lesions in dextran sodium sulfate-induced colitis. J
Immunol. 194:1882–1893. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liang YN, Yu JG, Zhang DB, Zhang Z, Ren
LL, Li LH, Wang Z and Tang ZS: Indigo Naturalis ameliorates dextran
sulfate sodium-induced colitis in mice by modulating the intestinal
microbiota community. Molecules. 24(4086)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zeng SL, Li SZ, Xiao PT, Cai YY, Chu C,
Chen BZ, Li P, Li J and Liu EH: Citrus polymethoxyflavones
attenuate metabolic syndrome by regulating gut microbiome and amino
acid metabolism. Sci Adv. 6(eaax6208)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ye Z, Zhang N, Wu C, Zhang X, Wang Q,
Huang X, Du L, Cao Q, Tang J, Zhou C, et al: A metagenomic study of
the gut microbiome in Behcet's disease. Microbiome.
6(135)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Masella AP, Bartram AK, Truszkowski JM,
Brown DG and Neufeld JD: PADNAseq: Paired-end assembler for
illumina sequences. BMC Bioinformatics. 13:1–7. 2013.
|
|
30
|
Edgar RC: UPARSE: Highly accurate OTU
sequences from microbial amplicon reads. Nat Methods. 10:996–998.
2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang WF, Yang Y, Su X, Xu DY, Yan YL, Gao
Q and Duan MH: Deoxyschizandrin suppresses dss-induced ulcerative
colitis in mice. Saudi J Gastroenterol. 22:448–455. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nie J and Liu X: Leonurine attenuates
hyperalgesia in mice with induced adenomyosis. Med Sci Monit.
23:1701–1706. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li N, Xu Q, Liu Q, Pan D, Jiang Y, Liu M,
Liu M, Xu H and Lin C: Leonurine attenuates fibroblast-like
synoviocyte-mediated synovial inflammation and joint destruction in
rheumatoid arthritis. Rheumatology (Oxford). 56:1417–1427.
2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Olson A, Diebel LN and Liberati DM:
Exogenous phosphatidylcholine supplementation improves intestinal
barrier defense against Clostridium difficile toxin. J Trauma Acute
Care Surg. 77:570–575; discussion 576. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shang X, Pan H, Wang X, He H and Li M:
Leonurus japonicus Houtt.: Ethnopharmacology, phytochemistry
and pharmacology of an important traditional Chinese medicine. J
Ethnopharmacol. 152:14–32. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shen J, Cheng J, Zhu S, Zhao J, Ye Q, Xu
Y, Dong H and Zheng X: Regulating effect of baicalin on
IKK/IKB/NF-κB signaling pathway and apoptosis-related proteins in
rats with ulcerative colitis. Int Immunopharmacol. 73:193–200.
2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Haange SB, Jehmlich N, Hoffmann M, Weber
K, Lehmann J, von Bergen M and Slanina U: Disease development is
accompanied by changes in bacterial protein abundance and functions
in a refined model of dextran sulfate sodium (DSS)-induced colitis.
J Proteome Res. 18:1774–1786. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rodríguez-Nogales A, Algieri F,
Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Fernández-Caballero
JA, García F, Rodríguez-Cabezas ME and Gálvez J: The administration
of Escherichia coli Nissle 1917 ameliorates development of
DSS-induced colitis in mice. Front Pharmacol. 9(468)2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li M, Wu Y, Hu Y, Zhao L and Zhang C:
Initial gut microbiota structure affects sensitivity to DSS-induced
colitis in a mouse model. Sci China Life Sci. 61:762–769.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chen YJ, Wu H, Wu SD, Lu N, Wang YT, Liu
HN, Dong L, Liu TT and Shen XZ: Parasutterella, in
association with irritable bowel syndrome and intestinal chronic
inflammation. J Gastroenterol Hepatol. 33:1844–1852.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ju T, Kong JY, Stothard P and Willing BP:
Defining the role of Parasutterella, a previously
uncharacterized member of the core gut microbiota. ISME J.
13:1520–1534. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sheng L, Jena PK, Liu HX, Hu Y, Nagar N,
Bronner DN, Settles ML, Bäumler AJ and Wan YY: Obesity treatment by
epigallocatechin-3-gallate-regulated bile acid signaling and its
enriched Akkermansia muciniphila. FASEB J: Jun 8, 2018 (Epub
ahead of print). doi: 10.1096/fj.201800370R.
|
|
43
|
Moreira GV, Azevedo FF, Ribeiro LM, Santos
A, Guadagnini D, Gama P, Liberti EA, Saad M and Carvalho C:
Liraglutide modulates gut microbiota and reduces NAFLD in obese
mice. J Nutr Biochem. 62:143–154. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Demirci M, Tokman HB, Uysal HK, Demiryas
S, Karakullukcu A, Saribas S, Cokugras H and Kocazeybek BS: Reduced
Akkermansia muciniphila and Faecalibacterium
prausnitzii levels in the gut microbiota of children with
allergic asthma. Allergol Immunopathol (Madr). 47:365–371.
2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Kosciow K and Deppenmeier U:
Characterization of a phospholipid-regulated beta-galactosidase
from Akkermansia muciniphila involved in mucin degradation.
Microbiologyope: Feb 6, 2019.
|
|
46
|
McGaughey KD, Yilmaz-Swenson T, Elsayed
NM, Cruz DA, Rodriguiz RM, Kritzer MD, Peterchev AV, Roach J,
Wetsel WC and Williamson DE: Relative abundance of
Akkermansia spp. and other bacterial phylotypes correlates
with anxiety- and depressive-like behavior following social defeat
in mice. Sci Rep. 9(3281)2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Cruz-Aguliar RM, Wantia N, Clavel T,
Vehreschild MJ, Buch T, Bajbouj M, Haller D, Busch D, Shmid RM and
Stein-Thoeringer CK: An open-labeled study on fecal microbiota
transfer in irritable bowel syndrome patients reveals improvement
in abdominal pain associated with the relative abundance of
Akkermansia muciniphila. Digestion. 100:127–138.
2019.PubMed/NCBI View Article : Google Scholar
|
